1. Home
  2. MESO vs DRVN Comparison

MESO vs DRVN Comparison

Compare MESO & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$16.47

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Driven Brands Holdings Inc.

DRVN

Driven Brands Holdings Inc.

HOLD

Current Price

$13.33

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MESO
DRVN
Founded
2004
1972
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Automotive Aftermarket
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
MESO
DRVN
Price
$16.47
$13.33
Analyst Decision
Strong Buy
Buy
Analyst Count
1
8
Target Price
N/A
$18.33
AVG Volume (30 Days)
180.2K
866.4K
Earning Date
02-26-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
146.70
EPS
N/A
0.54
Revenue
N/A
$1,862,438,000.00
Revenue This Year
$629.74
N/A
Revenue Next Year
$30.65
$1.53
P/E Ratio
N/A
$25.11
Revenue Growth
N/A
N/A
52 Week Low
$13.05
$9.80
52 Week High
$21.50
$18.60

Technical Indicators

Market Signals
Indicator
MESO
DRVN
Relative Strength Index (RSI) 48.95 51.37
Support Level $15.37 $11.97
Resistance Level $17.10 $13.49
Average True Range (ATR) 0.44 0.42
MACD -0.09 0.11
Stochastic Oscillator 1.06 70.38

Price Performance

Historical Comparison
MESO
DRVN

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

About DRVN Driven Brands Holdings Inc.

Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments; Take 5, Franchise Brands, and Auto Glass Now. It derives maximum revenue from Take 5 Segment. Geographically, the company operates into United States, Canada and Rest of the World.

Share on Social Networks: